盐酸苯氧丙酚胺 化学药品说明书异克舒令|药物应用信息
Ki: 13.65 μΜ (myometrial beta-adrenergic receptor), 3.48 μΜ (placcntal beta-adrenergic receptor) NMDA receptor
Results show that Isoxsuprine hydrochloride inhibits circular chemorepellent induced defect (CCID) formation dose dependently (5 to 60 μM) and also inhibits 12(S)-HETE synthesis. Furthermore, Isoxsuprine hydrochloride is the only drug inhibiting the induction of all three mobility markers (MLC2, MYPT and paxillin).
Total infarct volume in vehicle-treated animals is 279±25 mm 3 compare to 137±18 mm 3 in Isoxsuprine hydrochloride-treated animals.